| 000 | 00856 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514184530.0 | ||
| 264 | 0 | _c20040520 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a1548-9825 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 245 | 0 | 0 |
_aTobias, W.H.O. at odds over drug standards. _h[electronic resource] |
| 260 |
_bMedicine & health (1997) _cMar 2004 |
||
| 300 |
_a2-3 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xeconomics |
| 650 | 0 | 4 |
_aAntimalarials _xeconomics |
| 650 | 0 | 4 |
_aAntitubercular Agents _xeconomics |
| 650 | 0 | 4 | _aDrug Industry |
| 650 | 0 | 4 |
_aDrugs, Generic _xeconomics |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHealth Services Accessibility |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aWorld Health Organization |
| 773 | 0 |
_tMedicine & health (1997) _gvol. 58 _gno. 13 _gp. 2-3 |
|
| 999 |
_c14801613 _d14801613 |
||